Stealth virus nucleic acids and related methods
CA 2282858 A1 · Owner: Martin, William John · Inventors: Martin, William John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Stealth viruses comprise a molecularly heterogeneous grouping of atypically structured, vacuolating cytopathic viruses that cause persistent systemic , infection often with neuropsychiatric and potentially with oncogenic and autoimmune manifestations, in the absence of significant anti-viral inflammation. The appearance, progression and host range characteristics of the cytopathic effect (CPE) distinguish stealth viruses from conventional human cytopathic viruses, including herpesviruses, enteroviruses and adenoviruses. Electron microscopy, serology and molecular-based assays can be used to further differentiate stealth viruses from conventional viruses. Stealth viruses can …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 30, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 30, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 30, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.